BlackRock Inc. raised its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 21,593.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,683,531 shares of the company’s stock after buying an additional 6,652,722 shares during the period. BlackRock Inc. owned 12.71% of Nu Skin Enterprises worth $371,201,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Nu Skin Enterprises by 11.8% in the first quarter. Vanguard Group Inc. now owns 6,011,632 shares of the company’s stock valued at $333,887,000 after buying an additional 634,951 shares in the last quarter. Wellington Management Group LLP increased its stake in Nu Skin Enterprises by 7.3% in the first quarter. Wellington Management Group LLP now owns 1,944,383 shares of the company’s stock worth $107,991,000 after buying an additional 131,493 shares in the last quarter. Schroder Investment Management Group increased its stake in Nu Skin Enterprises by 139.4% in the first quarter. Schroder Investment Management Group now owns 1,711,619 shares of the company’s stock worth $94,687,000 after buying an additional 996,731 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Nu Skin Enterprises by 5.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,003,108 shares of the company’s stock worth $55,712,000 after buying an additional 55,882 shares during the period. Finally, William Blair Investment Management LLC increased its position in Nu Skin Enterprises by 12.4% in the first quarter. William Blair Investment Management LLC now owns 900,078 shares of the company’s stock worth $49,990,000 after buying an additional 98,952 shares during the period. 85.58% of the stock is owned by institutional investors and hedge funds.
Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 0.47% during trading on Friday, reaching $63.67. The company’s stock had a trading volume of 309,462 shares. Nu Skin Enterprises, Inc. has a 52-week low of $46.35 and a 52-week high of $66.04. The stock’s 50 day moving average price is $62.17 and its 200-day moving average price is $55.69. The stock has a market cap of $3.36 billion, a price-to-earnings ratio of 21.13 and a beta of 1.32.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.01. The firm had revenue of $499.10 million for the quarter, compared to analyst estimates of $493.65 million. Nu Skin Enterprises had a return on equity of 23.45% and a net margin of 7.48%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $0.42 EPS. Equities analysts anticipate that Nu Skin Enterprises, Inc. will post $3.12 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This piece was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/29/nu-skin-enterprises-inc-nysenus-shares-bought-by-blackrock-inc-updated-updated-updated.html.
A number of research firms have issued reports on NUS. Pivotal Research reiterated a “buy” rating and issued a $65.00 target price on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Sidoti cut Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price on the stock. in a research report on Wednesday, April 26th. Finally, Bank of America Corporation lifted their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research report on Monday, July 10th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company’s stock. Nu Skin Enterprises has a consensus rating of “Hold” and an average target price of $62.25.
In other news, General Counsel D Matthew Dorny sold 8,000 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $56.39, for a total value of $451,120.00. Following the completion of the transaction, the general counsel now owns 52,730 shares in the company, valued at approximately $2,973,444.70. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Over the last quarter, insiders sold 32,250 shares of company stock worth $1,956,770. Corporate insiders own 5.20% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.